Bringing the fundamentals into focus…
Back to Amphastar Pharmaceuticals, Inc.
How Amphastar Pharmaceuticals, Inc. stacks up
AMPH · against 460 other Healthcare companies of similar size
Profitability
67/ 100
Above the middle of the pack.
Ranked #133 of 461 · scores higher than 70% of peers
Bars: peers in each 10-point band of the profitability score52 peers with a profitability score of 60–69, including AMPH · Click a bar to see the companies
Why profitability scores 67?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its operating margin, return on assets and return on invested capital, which are stronger than most Healthcare peers.
- a higher return on invested capital: stronger than 61% of peers. Return on invested capital: 7.8% vs peer median 4.7%
- a higher return on assets: stronger than 69% of peers. Return on assets: 4.5% vs peer median 1.7%
- a wider operating margin: stronger than 73% of peers. Operating margin: 15.7% vs peer median 7.1%
Metric by metric
Position: dot = AMPH, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | AMPH | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 436 reported | 7.8% | 5.1% | 63% | 33% | |
| Operating marginHigher is better · 432 reported | 15.7% | 6.9% | 77% | 33% | |
| Return on assetsHigher is better · 446 reported | 4.5% | 1.7% | 73% | 33% | |
| Return on equityHigher is better · 428 reported | 10.3% | 3.0% | 74% | Context only | |
| Gross marginHigher is better · 480 reported | 47.7% | 48.1% | 50% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around AMPHScores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score